Skip to main content
. 2012 May 16;303(2):R159–R167. doi: 10.1152/ajpregu.00499.2011

Table 2.

Indices of trabecular and cortical bone formation and resorption measured in the distal femoral metaphysis and middiaphysis at time of death (34 wk)

Values at Time of Death
Control 1x-HLU 2x-HLU 3x-HLU
Metaphysis
    Trabecular
        MS/BS, % 2.9 ± 1.0 2.7 ± 0.84 2.1 ± 1.0 2.1 ± 0.67
        MAR, μm/day 0.31 ± 0.17 0.23 ± 0.21 0.16 ± 0.14 0.06 ± 0.07a
        BFR/BS × 10−3, 11 ± 9.1 6.4 ± 6.8 3.9 ± 3.8 1.8 ± 2.3a
        μm3•μm−2•day−1
        Oc.S/BS, % 13 ± 4.5 15 ± 4.1 18 ± 2.8 16 ± 5.6
        # Without Double Label 0 3 3 5
Diaphysis
    Endocortical
        MS/BS, % 9.1 ± 5.0 16 ± 10 9.4 ± 9.3 14 ± 3.5
        MAR, μm/day 0.22 ± 0.13 0.15 ± 0.16 0.17 ± 0.18 0.30 ± 0.24
        BFR/BS × 10−3, 22 ± 20 26 ± 27 28 ± 48 44 ± 30
        μm3•μm−2•day−1
        Oc.S/BS, % 15 ± 7.9 13 ± 5.9 16 ± 10.9 12 ± 8.2
        # Without Double Label 1 1 2 1
    Periosteal
        MS/BS, % 3.7 ± 6.1 13 ± 10 7.3 ± 5.2 11 ± 12
        MAR, μm/day 0.08 ± 0.11 0.12 ± 0.08 0.14 ± 0.17 0.19 ± 0.19
        BFR/BS × 10−3, 8.5 ± 18 20 ± 21 17 ± 29 26 ± 25
        μm3•μm−2•day−1
        Oc.S/BS, % 0.00 ± 0.00 0.31 ± 0.58 0.52 ± 1.0 0.32 ± 0.72
        # Without Double Label 4 2 2 2

Data are shown as means ± SD. Groups were compared using ANOVA followed by SNK. Letters denote significant differences (P < 0.05) between groups. aAny group different from control. MS/BS, % mineralizing surface; MAR, mineralization apposition rate; BFR/BS, bone formation rate; Oc.S/BS, osteoclast surface.